Early administration of tranexamic acid in trauma patients

The Lancet

Volumn 378, Issue 9785, 2011, Pages 27-28

  Yeguiayan, Jean Michel ^a   Rosencher, Nadia ^b,c   Vivien, B ^c,d  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; TRANEXAMIC ACID;

BLEEDING; DEATH; DRUG EFFICACY; EMERGENCY HEALTH SERVICE; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INJURY SCALE; LETTER; PENETRATING TRAUMA; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 79959934457     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61015-5     Document Type: Letter

References (3)

1. The CRASH-2 collaborators The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Lancet 377 2011 1096 1101
2. JM Yeguiayan, D Garrigue, C Binquet et al. Medical pre-hospital management reduces mortality in severe blunt trauma: a prospective epidemiological study Crit Care 15 2011 R34
3. IG Stiell, LP Nesbitt, W Pickett et al. The OPALS Major Trauma Study: impact of advanced life-support on survival and morbidity CMAJ 178 2008 1141 1152 (Pubitemid 351596225)